A free trade agreement (FTA) with the EU is a top priority for the Thai government, while businesses on both sides support a ...

EU mid-market update: Trump adds Middle East tensions to macro picture as trade war keeps volatility high; Novo Nordisk rises ...

Symphony Ltd (BOM:517385) reports a 49% increase in standalone top line and announces strategic measures to tackle forex losses and doubtful debts.

While some of the initial zeal around localized vaccine production in Africa has waned since the height of the COVID-19 pandemic, efforts to bolster the continent’s immunization autonomy—especially | ...

Authorities in many countries are scrambling for solutions to mounting shortages of medicine. Will any of them work?

GSK’s NgG shot is based on generalised modules ... France, Germany, Spain, Brazil, the Philippines, and South Africa, with a readout expected in 2025. Meanwhile, some research has found that ...

Caitlin Clark has been busy working on her game this offseason with the Indiana Fever, while some of her teammates stayed active locally and overseas.

It produces, distributes, and sells beer and PepsiCo products in Brazil and other Latin American ... 40% below our fair value estimate of $55. GSK is one of the largest pharmaceutical and vaccine ...

January 13, 2025--(BUSINESS WIRE)--GSK plc (LSE/NYSE: GSK) and IDRx, Inc. (IDRx) today announced that they have entered into an agreement under which GSK will acquire IDRx, a Boston-based ...

British pharma giant GSK is heading back to school, pledging up to 50 million pounds sterling (about $62.4 million) to work with the University of Oxford on a cancer vaccine research program.

Depemokimab data reveals 72% reduction in hospitalizations; projected sales hit £4 billion. GSK plc GSK expects strong momentum in the specialty business segment to continue with growth from ...

In a deal worth up to $1.15 billion, GSK is acquiring precision medicine biotech IDRx and its phase 3-ready gastrointestinal cancer asset. “We really became impressed with what IDRx had achieved ...